Children with atopic dermatitis respond more rapidly to dupilumab treatment in comparison to adolescents and adults

被引：0
|
作者：
Berdyshev, E. [1 ]
Goleva, E. [1 ]
Danby, S. [2 ]
Bronoff, A. [1 ,3 ]
Agueusop, I. [3 ]
Zahn, J. [4 ]
Gloaguen, E. [5 ]
Bissonnette, R. [6 ]
Boguniewicz, M. [1 ]
Ong, P. [7 ]
Zhang, A. [8 ]
Cork, M. [2 ]
Leung, D. [1 ]
机构：
[1] Natl Jewish Hlth, Denver, CO USA
[2] Univ Sheffield, Sheffield, S Yorkshire, England
[3] Sanofi, Franckfurt, Germany
[4] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[5] Sanofi, Chilly Mazarin, France
[6] Innovaderm Res, Montreal, PQ, Canada
[7] Childrens Hosp Los Angeles, Los Angeles, CA USA
[8] Sanofi, Cambridge, MA USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2024年 / 144卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
280
引用
收藏
页码：S48 / S48
页数：1
相关论文
共 50 条
  • [1] Dupilumab for the treatment of adolescents with atopic dermatitis
    Senner, Sonja
    Seegraber, Marlene
    Frey, Surina
    Kendziora, Benjamin
    Eicher, Laurie
    Wollenberg, Andreas
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (07) : 641 - 650
  • [2] Dupilumab: a comparison of infection rates across atopic dermatitis trials in adults, adolescents, children and infants
    Lio, Peter
    Beck, Lisa A.
    Shi, Vivian Y.
    Chen, Zhen
    Khokhar, Faisal A.
    Cyr, Sonya L.
    Gonzalez, Tayler
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [3] Dupilumab for children and adolescents with atopic dermatitis: An Asian perspective
    Chia, Shi Yun
    Wee, Lynette Wei Yi
    Koh, Mark Jean Aan
    DERMATOLOGIC THERAPY, 2021, 34 (03)
  • [4] Comparison of response between adults and adolescents in patients with severe atopic dermatitis treated with dupilumab
    Mastorino, Luca
    Vecco, Cristina
    Cantafio Duo, Vania L.
    Panzone, Michele
    Gelato, Federica
    Gallo, Giuseppe
    Merli, Martina
    Pala, Valentina
    Quaglino, Pietro
    Ribero, Simone
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2023, 158 (04) : 362 - 363
  • [5] A Review of Phase 3 Trials of Dupilumab for the Treatment of Atopic Dermatitis in Adults, Adolescents, and Children Aged 6 and Up
    Cather, Jennifer
    Young, Melodie
    DiRuggiero, Douglas C.
    Tofte, Susan
    Williams, Linda
    Gonzalez, Tayler
    DERMATOLOGY AND THERAPY, 2022, 12 (09) : 2013 - 2038
  • [6] A Review of Phase 3 Trials of Dupilumab for the Treatment of Atopic Dermatitis in Adults, Adolescents, and Children Aged 6 and Up
    Jennifer Cather
    Melodie Young
    Douglas C. DiRuggiero
    Susan Tofte
    Linda Williams
    Tayler Gonzalez
    Dermatology and Therapy, 2022, 12 : 2013 - 2038
  • [7] A Review of Dupilumab in the Treatment of Atopic Dermatitis in Infants and Children
    Wang, Mingyue
    Gao, Xing-Hua
    Zhang, Li
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 941 - 951
  • [8] Dupilumab for treatment of atopic dermatitis
    Seegraeber, Marlene
    Srour, Jerome
    Walter, Alexandra
    Knop, Macarena
    Wollenberg, Andreas
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (05) : 467 - 474
  • [9] Dupilumab for the Treatment of Atopic Dermatitis
    Ferreira, S.
    Torres, T.
    ACTAS DERMO-SIFILIOGRAFICAS, 2018, 109 (03): : 230 - 240
  • [10] Dupilumab for the treatment of atopic dermatitis
    不详
    PEDIATRIC DERMATOLOGY, 2021, 38 (06) : E643 - E644
12345